LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
2020 · Nature Communications · 190 citations
https://doi.org/10.1038/s41467-020-19349-w
J
Jingru Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
1.7K
Citations
22
h-index
42
i10-index
Jingru Wang is an academic researcher from Soochow University. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Hippo pathway signaling and YAP/TAZ & Cancer-related molecular mechanisms research. The author has an h-index of 22, co-authored 101 publications.
ORCID: 0000-0002-3327-0686Papers by this author
works<p>Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid</p>
2020 · International Journal of Nanomedicine · 18 citations
https://doi.org/10.2147/ijn.s240436
TRIP6 promotes inflammatory damage via the activation of TRAF6 signaling in a murine model of DSS-induced colitis
2022 · Journal of Inflammation · 9 citations
https://doi.org/10.1186/s12950-021-00298-0
A comprehensive analysis of the expression, immune infiltration, prognosis and partial experimental validation of CHST family genes in gastric cancer
2023 · Translational Oncology · 4 citations
https://doi.org/10.1016/j.tranon.2023.101843
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat